Joshua Michael Hare
Net Worth

Last updated:

What is Joshua Michael Hare net worth?

The estimated net worth of Dr. Joshua Michael Hare is at least $1,986,093 as of 11 Apr 2024. He owns shares worth $34,613 as insider, has earned $871,480 from insider trading and has received compensation worth at least $1,080,000 in Longeveron Inc..

What is the salary of Joshua Michael Hare?

Dr. Joshua Michael Hare salary is $270,000 per year as Co-Founder, Chief Science Officer & Chairman in Longeveron Inc..

How old is Joshua Michael Hare?

Dr. Joshua Michael Hare is 62 years old, born in 1963.

What stocks does Joshua Michael Hare currently own?

As insider, Dr. Joshua Michael Hare owns shares in one company:

Company Title Shares Price per share Total value
Longeveron Inc. (LGVN) Co-Founder, Chief Science Officer & Chairman 42,553 $0.81 $34,613

What does Longeveron Inc. do?

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

LGVN logo
LGVN
Longeveron Inc.
$0.81

Joshua Michael Hare insider trading

Longeveron Inc.

Dr. Joshua Michael Hare has made 6 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he purchased 42,553 units of LGVN stock worth $100,000 on 11 Apr 2024.

The largest trade he's ever made was exercising 115,000 units of LGVN stock on 12 Feb 2021. As of 11 Apr 2024 he still owns at least 42,553 units of LGVN stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Class A Common Stock 42,553 $2.35 $100,000
Purchase
Warrant (right to buy) 42,553 $2.35 $100,000
Purchase
Warrant (right to buy) 106,383 $2.35 $250,000
Purchase
Class A Common Stock 106,383 $2.35 $250,000
Option
Subscription Rights (right to buy) 5,000 $3 $15,000
Option
Common Stock 5,000 $3 $15,000
Option
Subscription Rights (right to buy) 30,000 $3 $90,000
Option
Common Stock 30,000 $3 $90,000
Sale
Subscription Rights (right to buy) 50,000 $3 $150,000
Sale
Common Stock 20,000 $4.28 $85,600
Sale
Common Stock 20,000 $3.74 $74,800
Sale
Common Stock 100,000 $3.61 $361,000
Sale
Common stock 78 $10 $780
Sale
Common stock 19,922 $10 $199,300
Purchase
Common stock 2,500 $3.69 $9,225
Purchase
Common stock 3,015 $3.39 $10,221
Purchase
Common stock 1,985 $3.38 $6,709
Purchase
Common Stock 115,000 $6.08 $698,855
Purchase
Common Stock 103,000 $9.12 $938,845

Longeveron key executives

Longeveron Inc. executives and other stock owners filed with the SEC:

  • Dr. Joshua Michael Hare (62) Co-Founder, Chief Science Officer & Chairman
  • Mr. Geoff Green M.B.A. (51) Chief Executive Officer
  • Mr. James Clavijo CPA (59) Chief Financial Officer & Treasurer
  • Mr. Paul T. Lehr J.D. (57) International Executive Director, Gen. Counsel & Sec.